Latest Articles

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several points of progress in CGT R&D worth watching are discussed.

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, providing clues for developing longer-lasting vaccines.

Where do the greatest opportunities for collaboration across life sciences disciplines lie today – and what’s needed to unlock them? We asked the experts.

Middle-down proteomics addresses the limitations of conventional bottom-up approaches by providing deeper insight into proteoform analysis.

Technology Networks spoke with Dr. Samantha Pearman-Kanza to learn more about the benefits (and potential pitfalls) of going paperless in the lab and some of the research advancing digital technologies.

Dr. Hazel X. Ang shares their experiences navigating STEMM, reflecting on progress, remaining barriers and the everyday actions that make research environments more inclusive.

Dr. Tyler Brown discusses his experiences of working in STEMM and highlights how the industry can foster a more inclusive workplace culture.

Queer scientist Max Fisher shares insights on identity, inclusion and the simple changes that help create safer, more supportive lab spaces for LGBTQIA+ researchers.

This article explores how understanding the brain–immune ecosystem brings insights to the molecular mechanisms behind brain aging, facilitating research into immunotherapies for neurodegenerative diseases.

How can research labs reduce their environmental impact? Technology Networks asked two sustainability experts to find out.